P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 26 May 2017 | 9:59 pm

Novartis receives FDA approval for expanded use of Zykadia® in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)

In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared to 8.1 months with chemotherapy [1] more ...

Published 26 May 2017 | 8:17 am

AstraZeneca delivers new data on expanding portfolio of cancer medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

Lynparza's potential in BRCA-mutated metastatic breast cancer to be highlighted in plenary presentation of Phase III OlympiAD trial more ...

Published 25 May 2017 | 7:37 pm

FDA Advisory Committee Recommends Approval of Pfizer's Proposed Biosimilar to Epogen®/Procrit® Across All Indications

Thursday, May 25, 2017 - 1:16pm EDT "The Committee's recommendation reinforces the potential value of biosimilars in expanding access to additional high-quality treatment more ...

Published 25 May 2017 | 10:06 am

Newtrition® Asia Research Grant awardees present studies at China Nutrition Science Congress

Chinese grant awardee Dr. Yu presents findings from recently published study, showing that plant sterols in soy milk benefit heart health among elderly in China more ...

Published 24 May 2017 | 2:05 pm

Master Builders Solutions® at Barcelona Building Construmat

MasterSuna among finalists of the award for the most innovative product more ...

Published 24 May 2017 | 2:04 pm

Takeda Showcases Broadened Oncology Portfolio Through Data Presentations at Upcoming Medical Meetings

- Takeda to Share Data at the American Society of Clinical Oncology (ASCO) Annual Meeting, the Congress of the European Hematology Association (EHA) and the International more ...

Published 24 May 2017 | 1:00 pm

Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation

Wednesday, May 24, 2017 - 6:45am EDT Pfizer Inc. (NYSE:PFE) today announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Corporation of more ...

Published 24 May 2017 | 3:09 am

Capsules Now Available for the Treatment of Multiple Myeloma in Japan

Osaka, Japan, May 24, 2017 - Takeda Pharmaceutical Company Limited ( TSE: 4502 ) today announced that NINLARO more ...

Published 23 May 2017 | 9:07 pm

Key to Ending Trachoma

At Pfizer, we believe socially responsible entrepreneurship is essential to improving the health of every individual. In the effort to eliminate trachoma, the world's leading more ...

Published 23 May 2017 | 9:07 pm

A Blueprint to Eliminate NTDs like Trachoma

In 2011, 325 million people required treatment for trachoma. Today, that number has dropped dramatically to 182 million, a roughly 50 percent decrease. more ...

Pharma Documentation Ring:
24 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Berlin, September 26 – 29, 2017

Next Annual General Meeting, Berlin, September 26 – 29, 2017